Abstract
The increasing exposure of human populations to excessive levels of metals continues to represent a matter of public health concern. Several biomarkers have been studied and proposed for the detection of adverse health effects induced by lead (Pb), arsenic (As), and manganese (Mn); however, these studies have relied on exposures to each single metal, which fails to replicate real-life exposure scenarios. These three metals are commonly detected in different environmental, occupational, and food contexts and they share common neurotoxic effects, which are progressive and once clinically apparent may be irreversible. Thus, chronic exposure to low levels of a mixture of these metals may represent an additive risk of toxicity. Building upon their shared mechanisms of toxicity, such as oxidative stress, interference with neurotransmitters, and effects on the hematopoietic system, we address putative biomarkers, which may assist in assessing the onset of neurological diseases associated with exposure to this metal mixture.
Similar content being viewed by others
References
Agency for Toxic Substances and Disease Registry (ASTDR), U.S. Department of Health and Human Sciences (2004) Issue paper on the human health effects of metals
Martinez-Finley EJ, Chakraborty S, Fretham SJB, Aschner M (2012) Cellular transport and homeostasis of essential and nonessential metals. Metallomics 4(7):593–605
Wong CSC, Li X, Thornton I (2006) Urban environmental geochemistry of trace metals. Environ Pollut 142:1–16
Fairbrother A, Wenste R, Sappington K, Wood W (2007) Framework for metals risk assessment. Ecotoxicol Environ Safety 68:145–227
Agency for Toxic Substances and Disease Registry (ASTDR), U.S. Department of Health and Human Sciences (2000) Supplementary guidance for conducting health risk assessment of chemical mixtures
Kortenkamp and Faust (2009) State of the Art Report on Mixture Toxicity—Final Report. UE Commission. http://ec.europa.eu/environment/chemicals/effects/pdf/reportmixture_toxicity.pdf, 13th June 2014, 2 pm
Pohl HR, Hansen H, Chou CHSJ (1997) Public health guidance values for chemical mixtures: current practice and future directions. Regul Toxicol Pharmacol 26:322–329
Kordas K, Queirolo EI, Ettinger AS, Wright RO, Stoltzfus RJ (2010) Prevalence and predictors of exposure to multiple metals in preschool children from Montevideo, Uruguay. Sci Total Environ 408:4488–4494
Calderon J, Ortiz-Perez D, Yanez L, Díaz-Barriga F (2003) Human exposure to metals. Pathways of exposure, biomarkers of effect, and host factors. Ecotoxicol Environ Saf 56:93–103
Lister LJ, Svendsen C, Wright J, Hooper HL, Spurgeon DJ (2011) Modelling the joint effects of a metal and a pesticide on reproduction and toxicokinetics in Lumbricid earthworms. Environ Int 37:663–670
Abboud P, Wilkinson KJ (2013) Role of metal mixtures (Ca, Cu and Pb) on Cd bioaccumulation and phytochelatin production by Chlamydomonas reinhardtii. Environ Poll 179:33–38
Agency for Toxic Substances and Disease Registry (ASTDR), U.S. Department of Health and Human Sciences (2004). Interaction profile for: Lead, Manganese, Zinc and Copper
Lucchini R, Zimmerman N (2009) Lifetime cumulative exposure as a threat for neurodegeneration: need for prevention strategies on a global scale. NeuroToxicology 30(6):1144–1148
Emerit J, Edeas M, Bricaire F (2004) Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 58:39–46
Csavina J, Field J, Taylor MP, Gao S, Landázuri A, Betterton EA, Sáez AE (2012) A review on the importance of metals and metalloids in atmospheric dust and aerosol from mining operations. Sci Total Environ 433:58–73
Agency for Toxic Substances and Disease Registry ASTDR), U.S. Department of Health and Human Sciences, (2007) b. Toxicological profile for Lead
Agency for Toxic Substances and Disease Registry (ASTDR), U.S. Department of Health and Human Sciences, (2007) c. Toxicological profile for Manganese
Finkelstein Y, Milatovic D, Aschner M (2007) Modulation of cholinergic systems by manganese. NeuroToxicology 28:1003–1014
Järup L (2003) Hazards of heavy metal contamination. Br Med Bull 68:167–182
Patrick L (2006) Lead toxicity, a review of the literature. Part I: exposure, evaluation, and treatment. Altern Med Rev 11(1):2–22
Rodríguez VM, Jiménez-Capdeville ME, Giordano M (2003) The effects of arsenic exposure on the nervous system. Toxicol Lett 145:1–18
Casarett & Doull’s (2013) Toxicology: the basic science of poisons. 8th Ed. McGraw-Hill
Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283(2–3):65–87
Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ (2011) Arsenic exposure and toxicology: a historical perspective. Toxicol Sci 123(2):305–332
Moinuddin M (2004) Drinking death in groundwater: arsenic contamination as a threat to water security for Bangladesh. ACDIS Occasional Paper. http://acdis.illinois
Agency for Toxic Substances and Disease Registry (ASTDR), U.S. Department of Health and Human Sciences, (2007) a. Toxicological profile for Arsenic
Kakkar P, Jaffery FN (2005) Biological markers for metal toxicity. Environ Toxicol Pharmacol 19:335–349
Santamaria AB (2008) Manganese exposure, essentiality & toxicity. Indian J Med Res 128:484–500
Wright RO, Amarasiriwardena C, Woolf AD, Jime R, Bellinger DC (2006) Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. NeuroToxicology 27:210–216
Gulson B, Mizon K, Taylor A, Korsch M, Stauber J, Davise JJM, Louie H, Wu M, Swan H (2006) Changes in manganese and lead in the environment and young children associated with the introduction of methylcyclopentadienyl manganese tricarbonyl in gasoline—preliminary results. Environ Res 100:100–114
Menkes DB, Fawcett JP (1997) Too easily lead? Health effects of gasoline additives. Environ Health Perspect 105(3):270–273
Weiss B (2006) Economic implications of manganese neurotoxicity. NeuroToxicology 27:362–368
Nelson G, Criswell SR, Zhang J, Murray J, Racette BA (2012) Research capacity development in South African manganese mines to bridge exposure and neuropathologic outcomes. NeuroToxicology 27:315–326
Basu N, Nama DH, Kwansaa-Ansah E, Renne EP, Nriagu JO (2011) Multiple metals exposure in a small-scale artisanal gold mining community. Environ Res 111:463–467
Choudhury H, Mudipalli A (2008) Potential considerations and concerns in the risk characterization for the interaction profiles of metals. Indian J Med Res 128:462–483
Dhatrak SV, Nandi SS (2009) Risk assessment of chronic poisoning among Indian metallic miners. Indian J Occup Environ Med 13(2):60–64
Rodriguez VM, Dufour L, Carrizales L, Diaz-Barriga F, Jimenez-Capdeville ME (1998) Effects of oral exposure to mining waste on in vivo dopamine release from rat striatum. Environ Health Perspect 106(8):487–491
Yim JH, Kim KW, Kim SD (2006) Effect of hardness on acute toxicity of metal mixtures using Daphnia magna: prediction of acid mine drainage toxicity. J Hazard Mater 38:16–21
Sansar W, Ahboucha S, Gamrani H (2011) Chronic lead intoxication affects glial and neural systems and induces hypoactivity in adult rat. Acta Histochem 113:601–607
Reckziegel P, Dias VT, Benvegnú D, Boufleur N, Barcelos RCS, Segat HJ, dos Pase CS, Santos FCMM, Bürger ME (2001) Locomotor damage and brain oxidative stress induced by lead exposure are attenuated by gallic acid treatment. Toxicol Let 203:74–81
Halatek T, Sinczuk-Walczak H, Rabieh S, Wasowicz W (2009) Association between occupational exposure to arsenic and neurological, respiratory and renal effects. Toxicol Appl Pharmacol 239:193–199
Lockitch G (1993) Perspectives on lead toxicity. Clin Biochem 26:371–381
Zheng W, Aschner M, Ghersi-Egeac JF (2003) Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol 192(1):1–11
Mameli O, Caria MA, Melis F, Solinas A, Tavera C, Ibba A, Tocco M, Flore C, Randaccio FS (2001) Neurotoxic effect of lead at low concentrations. Brain Res Bull 55(2):269–275
Moreira EG, Vassilieff I, Vassilieff VS (2001) Developmental lead exposure: behavioral alterations in the short and long term. Neurotoxicol Teratol 23:489–495
van Wijngaarden E, Winters PC, Cory-Slechta DA (2011) Blood lead levels in relation to cognitive function in older U.S. adults. NeuroToxicology 32:110–115
García-Chávez E, Jiménez I, Segura B, Del Razo LM (2006) Lipid oxidative damage and distribution of inorganic arsenic and its metabolites in the rat nervous system after arsenite exposure: influence of alpha tocopherol supplementation. NeuroToxicology 27:1024–1031
Yadav RS, Chandravanshi LP, Shukla RK, Sankhwar ML, Ansari RW, Shukla PK, Pant AB, Khanna VK (2011) Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats. NeuroToxicology 32(6):760–768
de Vizcaya-Ruiza A, Barbiera O, Ruiz-Ramos R, Cebrian ME (2009) Biomarkers of oxidative stress and damage in human populations exposed to arsenic. Mut Res 674:85–92
Mejía JJ, Díaz-Barriga F, Calderón J, Ríos C, Jiménez-Capdeville ME (1997) Effects of lead-arsenic combined exposure on central monoaminergic systems. Neurotoxicol Teratol 19(6):489–497
Health Canada, Water, Air & Climate Change Bureau (2008) Human health risk assessment for inhaled manganese Draft. http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hecssesc/pdf/air/out-ext/_consult/draft_ebauche/manganese-eng.pdf, 2th May 2014, 4 pm
Tjälve H, Henriksson J (1999) Uptake of metals in the brain via olfactory pathways. Neurotoxicology 20(2–3):181–195
Normandin L, Beaupre LA, Salehi F, St.-Pierre A, Kennedy G, Mergler D, Butterworth RF, Philippe S, Zayed J (2004) Manganese distribution in the brain and neurobehavioral changes following inhalation exposure of rats to three chemical forms of manganese. NeuroToxicology 25:433–441
Bowler RM, Gysens S, Diamond E, Nakagawa S, Drezgic M, Roels HA (2006) Manganese exposure: neuropsychological and neurological symptoms and effects in welders. NeuroToxicology 27:315–326
Kim HY, Lee CK, Lee JT, Moon CS, Ha SC, Kang SG, Kim DH, Kim HD, Ahn JH, Lee SB, Kang MG (2009) Effects of manganese exposure on dopamine and prolactin production in rat. NeuroReport 20(1):69–73
Shukla GS, Chandra SV (1987) Concurrent exposure to lead, manganese, and cadmium and their distribution to various brain regions, liver, kidney, and testis of growing rats. Arch Environ Contam Toxicol 16:303–310
Chandra SV, Mohd. Ali M, Saxena DK, Murthy RC (1981) Behavioral and neurochemical changes in rats simultaneously exposed to manganese and lead. Arch Toxicol 49:49–56
Kim Y, Kim BN, Hong YC, Shin MS, Yoo HJ, Kim JW, Bhang SY, Cho SC (2009) Co-exposure to environmental lead and manganese affects the intelligence of school-aged children. NeuroToxicology 30:564–571
Carrizales L, Razoa I, Tellez-Hernandez J, Torres-Nerioa R, Torres A, Batres LE, Cubillas AC, Dáaz-Barriga F (2006) Exposure to arsenic and lead of children living near a copper-smelter in San Luis Potosi, Mexico: importance of soil contamination for exposure. Environ Res 101:1–10
Wright RO, Baccarelli A (2009) Metals and neurotoxicology. J Nutr 137(12):2809–2813
Flora SJS (2011) Arsenic-induced oxidative stress and its reversibility. Free Rad Biol Med 51:257–281
Flora SJS, Bhadauria S, Pant SC, Dhaked RK (2005) Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats. Life Sci 77:2324–2337
Gurer H, Ercal N (2000) Can antioxidants be beneficial in the treatment of lead poisoning? Free Rad Biol Med 29(10):927–945
Milatovic D, Milatovic SZ, Gupta RC, Yu Y, Aschner M (2009) Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol 240:219–225
Erikson KM, Dobson AW, Dorman DC, Aschner M (2004) Manganese exposure and induced oxidative stress in the rat brain. Sci Total Environ 1(334–335):409–416
Franco R, Sánchez-Olea R, Reyes-Reyes EM, Panayiotidis MI (2009) Environmental toxicity, oxidative stress and apoptosis: Ménage à Trois. Mutat Res 674:3–22
Zhang S, Fu J, Zhou Z (2004) In vitro effect of manganese chloride exposure on reactive oxygen species generation and respiratory chain complexes activities of mitochondria isolated from rat brain. Toxicol in Vitro 18:71–77
Jain A, Yadav A, Bozhkov AI, Padalko VI, Flora SJS (2011) Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats. Ecotoxicol Environ Saf 74:607–614
Liccione JJ, Maines MD (1988) Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese. J Pharmacol Exp Ther 247(1):156–161
Malecki EA, Lo HC, Yang H, Davis CD, Ney DM, Greger JL (1995) Tissue manganese concentrations and antioxidant enzyme activities in rats given total parenteral nutrition with and without supplemental manganese. J Parenter Enteral Nutr 19(3):222–226
Ali N, Hoque A, Haque A, Salam KA, Karim R, Rahman A, Islam K, Saud ZA, Khalek A, Akhand AA, Hossain M, Mandal A, Karim R, Miyataka H, Himeno S, Hossain K (2010) Association between arsenic exposure and plasma cholinesterase activity: a population based study in Bangladesh. Environ Health 9(36):1–9
Ademuyiwa O, Ugbaja RN, Rotimi SO, Abama E, Okediran BS, Dosumu OA, Onunkwor BO (2007) Erythrocyte acetylcholinesterase activity as a surrogate indicator of lead-induced neurotoxicity in occupational lead exposure in Abeokuta, Nigeria. Environ Toxicol Pharmacol 24:183–188
Rosemberg DB, da Rocha RF, Rico EP, Zanotto- Filho A, Dias RD, Bogo MR, Bonan CD, Moreira JCF, Klamt F, Souza DO (2010) Taurine prevents enhancement of acetylcholinesterase activity induced by acute ethanol exposure and decreases the level of markers of oxidative stress in zebrafish brain. Neuroscience 171:683–692
Santos D, Milatovic D, Andrade V, Batoréu MC, Aschner M, Marreilha dos Santos AP (2012) The inhibitory effect of manganese on acetylcholinesterase activity enhances oxidative stress and neuroinflammation in the rat brain. Toxicology 292(2–3):90–98
Amal EA, Mona HM (2009) Protective effect of some antioxidants on the brain of adult male albino rats, Rattus rattus, exposed to heavy metals. Biosci Res 6(1):12–19
Ellingsen DG, Haug E, Gaarder PI, Bast-Pettersen R, Thomassen Y (2003) Endocrine and immunologic markers in manganese alloy production workers. Scand J Work Environ Health 29(3):230–238
Jones DC, Miller GW (2008) The effects of environmental neurotoxicants on the dopaminergic system: a possible role in drug addiction. Biochem Pharmacol 76:569–581
Prabhakarana K, Ghoshb D, Chapmana GD, Gunasekara PG (2008) Molecular mechanism of manganese exposure-induced dopaminergic toxicity. Brain Res Bull 76:361–367
Rodríguez VM, Limón-Pacheco JH, Carrizales L, Mendoza-Trejo MS, Giordano M (2010) Chronic exposure to low levels of inorganic arsenic causes alterations in locomotor activity and in the expression of dopaminergic and antioxidant systems in the albino rat. Neurotoxicol Teratol 32:640–647
Roses OE, Alvarez S, Conti MI, Nobile RA, Villaami EC (1989) Correlation between lead and prolactin in males exposed and unexposed to lead in Buenos Aires (Argentina) area. Bull Environ Contam Toxicol 42:438–442
Ghareeb DA, Hussien HM, Khalil AA, El-Saadani MA, Ali AN (2010) Toxic effects of lead exposure on the brain of rats: involvement of oxidative stress, inflammation, acetylcholinesterase, and the beneficial role of flaxseed extract. Toxicol Environ Chem 92:187–195
Shavali S, Sens DA (2008) Synergistic neurotoxic effects of arsenic and dopamine in human dopaminergic neuroblastoma SH-SY5Y cells. Toxicol Sci 102(2):254–261
Case AJ, Madsen JM, Motto DG, Meyerholz DK, Domann FE (2013) Manganese superoxide dismutase depletion in murine hematopoietic stem cells perturbs iron homeostasis, globin switching, and epigenetic control in erythrocyte precursor cells. Free Radical Biol Med 56:17–27
Cory-Slechta DA (1990) Alterations in tissue Pb distribution and hematopoietic indices during advanced age. Arch Toxicol 64(1):31–37
Pereira JA, Das P, Chaklader M, Chatterjee S, Basak P, Chaudhuri S, Law S (2010) Effects of inorganic arsenic on bone marrow hematopoietic cells: an emphasis on apoptosis and Sca-1/c-Kit positive population. J Stem Cells 5(3):117–127
Demasi M, Penatti CAA, Delucia RT, Bechara EJH (1996) The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias. Free Radical Biol Med 20(3):291–299
Hift RJ, Thunell S, Brun A (2011) Drugs in porphyria: from observation to a modern algorithm-based system for the prediction of porphyrogenicity. Pharmacol Ther 132(2):158–169
Kauppinen R (2005) Porphyrias. Lancet 365:241–252
Bleiberg J, Wallen M, Brodkin R, Applebaum IL, Newark NJ (1967) Industrially acquired porphyria. Arch Dermatol 89:793–797
Quintanilla-Vega B, Hernandez A, Mendoza-Figueroa T (1996) Reduction in porphyrin excretion as a sensitive indicator of lead toxicity in primary cultures of adult rat hepatocytes. Toxicol in Vitro 10:675–683
Ng JCT, Wang JP, Zheng B, Zhai C, Maddalena R, Liu F (2005) Urinary porphyrins as biomarkers for arsenic exposure among susceptible populations in Guizhou province, China. Toxicol Appl Pharmacol 206:176–184
Woods JS, Martin MD, Leroux BG, DeRouen TA, Bernardo MF, Luis HS, Leitão JG, Simmonds PL, Rue TC (2009) Urinary porphyrin excretion in normal children and adolescents. Clin Chim Acta 405:104–109
Maines MD (1980) Regional distribution of the enzymes of haem biosynthesis and the inhibition of 5-aminolaevulinate synthase by manganese in the rat brain. Biochem J 190:315–321
Qato MK, Maines MD (1985) Regulation of heme and drug metabolism activities in the brain by manganese. Biochem Biophys Res Commun 128(1):18–24
Adhikari A, Penatti CAA, Resende RR, Ulrich H, Britto LRG, Bechara EJH (2006) 5-Aminolevulinate and 4, 5-dioxovalerate ions decrease GABAA receptor density in neuronal cells, synaptosomes and rat brain. Brain Res 1093:95–104
Guolo M, Stella AM, Melito V, Parera V, Batle AMC (1996) Altered 5-aminolevulinic acid metabolism leading to pseudophorphyria in hemodialysed patients. lnt J Biochem Cell Bid 28:311–317
Ahamed M, Siddiqui MKJ (2007) Low level lead exposure and oxidative stress: current opinions. Clin Chim Acta 383:57–64
Ryter SW, Tyrrell RM (2000) The heme synthesis and degradation pathways: role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radical Biol Med 28(2):289–309
Onuki J, Chen Y, Teixeira PC, Schumachera RI, Medeiros MHG, Van Houten B, Di Mascio P (2004) Mitochondrial and nuclear DNA damage induced by 5-aminolevulinic acid. Arch Biochem Biophys 432:178–187
Moore MR (1998) The biochemistry of heme synthesis in porphyria and in the porphyrinurias. Clin Dermatol 16:203–223
Krishnamohan M, Qi L, Lam PKS, Moore MR, Ng JC (2007) Urinary arsenic and porphyrin profile in C57BL/6J mice chronically exposed to monomethylarsonous acid (MMAIII) for two years. Toxicol Appl Pharmacol 224:89–97
Ricchelli F (1995) New trends in photobiology—photophysical properties of porphyrins in biological membranes. J Photochem Photobiol 29:109–118
Rachakonda V, Pan TH, Le WD (2004) Biomarkers of neurodegenerative disorders: how good are they? Cell Res 14(5):349–360
Costa LG, Manzo L (1995) Biochemical markers of neurotoxicity: research and epidemiological applications. Toxicol Lett 77:137–144
Nielsen GD, Øvrebø S (2008) Background, approaches and recent trends for setting health-based occupational exposure limits: a minireview. Regul Toxicol Pharmacol 51:253–269
Phoon HW (1998) Manganese exposure and biological indicators. Sing Med J 29:93–94
Batterman S, Su FC, Jia C, Naidoo RN, Robins T, Naik I (2011) Manganese and lead in children’s blood and airborne particulate matter in Durban, South Africa. Sci Total Environ 409:1058–1068
Fukui Y, Miki M, Ukai H, Okamoto S, Takada S, Higashikawa K, Ikeda M (1999) Urinary lead as a possible surrogate of blood lead among workers occupationally exposed to lead. Int Arch Occup Environ Health 72:516–520
Moreira MFR, Neves EB (2008) Uso do chumbo em urina como indicador de exposição e sua relação com chumbo no sangue. Cad Saúde Pública, Rio de Janeiro 24(9):2151–2159
Marchiset-Ferlay N, Savanovitch C, Sauvant-Rocha MP (2012) What is the best biomarker to assess arsenic exposure via drinking water? Environ Int 39:150–171
Morton J, Mason H (2006) Speciation of arsenic compounds in urine from occupationally unexposed and exposed persons in the U.K. using a routine LC-ICP-MS Method. J Anal Toxicol 30:293–301
Chen CJ, Hsu L, Wang CH, Shihl WL, Hsu YH et al (2005) Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. Toxicol Appl Pharmacol 206:198–206
Bader M, Dietz MC, Ihrig A, Triebig G (1999) Biomonitoring of manganese in blood, urine and axillary hair following low-dose exposure during the manufacture of dry cell batteries. Int Arch Occup Environ Health 72:521–527
Cowan DM (2008) Exploring biomarkers of manganese exposure in humans and animals: the manganese-iron ratio as a potential tool for identification of early-onset manganism. Doctoral thesis
Slikker JTW, Bowyer JF (2005) Biomarkers of adult and developmental neurotoxicity. Toxicol Appl Pharmacol 206:255–260
Bergdahl IA, Grubb A, Schütz A, Desnick RJ, Wetmur JG, Sassa S, Skerfving S (1997) Lead binding to delta-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol 81(4):153–158
Scinicariello F, Murray HE, Moffett DB, Abadin HG, Sexton MJ, Fowler BA (2007) Lead and delta-aminolevulinic acid dehydratase polymorphism: where does it lead? A meta-analysis. Environ Health Perspect 115(1):35–41
Tian T, Ali B, Qin Y, Malik Z, Gill RA, Ali S, Zhou W (2014) Alleviation of lead toxicity by 5-aminolevulinic acid is related to elevated growth, photosynthesis, and suppressed ultrastructural damages in oilseed rape. Biomed Res Int. doi:10.1155/2014/530642. Epub 2014 Feb 11
Loffredo CA, Aposhian HV, Cebrian ME, Yamauchi H, Silbergeld EK (2003) Variability in human metabolism of arsenic. Environ Res 92(2):85–91
Antonelli R, Shao K, Thomas DJ, Sams R, Cowden J (2014) AS3MT, GSTO, and PNP polymorphisms: impact on arsenic methylation and implications for disease susceptibility. Environ Res 132:156–167
McClintock TR, Chen Y, Bundschuh J, Oliver JT, Navoni J, Olmos V, Lepori EV, Ahsan H, Parvez F (2012) Arsenic exposure in Latin America: biomarkers, risk assessments and related health effects. Sci Total Environ 1(429):76–91
Vinayagamoorthy N, Krishnamurthi K, Devi SS, Naoghare PK, Biswas R, Biswas AR, 2850, GSTM1, NQO1 genes and their correlation with biomarkers in manganese miners of Central India. Chemosphere 81(10): 1286–1291
Meeker JD, Rossano MG, Protas B, Diamond MP, Puscheck E, Daly D, Paneth N, Wirth JJ (2009) Multiple metals predict prolactin and thyrotropin (TSH) levels in men. Environ Res 109(7):869–873
Alessio L, Luchini R (2006) Prolactin changes as a consequence of chemical exposure. Environ Health Perspect 114(10):573–574
Goering PL, Fowler BA (1987) Metal constitution of metallothionein influences inhibition of 5-aminolaevulinic acid dehydratase (porphobilinogen synthase) by lead. Biochem J 245:339–345
Seth TD, Agarwal LN, Satija NK, Hasan MZ (1976) The effect of lead and cadmium on liver, kidney, and brain levels of cadmium, copper, lead, manganese, and zinc, and on erythrocyte ALAD activity in mice. Bull Environ Contam Toxicol 16(2):190–196
Chibe M, Sinohara A, Matsushita K, Watanabe H, Inaba Y (1996) Indices of lead exposure in blood and urine of lead exposed workers and concentrations of major trace elements and activities of SOD, GSH-Px and catalase in their blood. J Exp Med 178:49–62
Rocha JBT, Pereira ME, Emanuell T, Christofari RS, Souza DO (1995) Effect of treatment with mercury chloride and lead acetate during the second stage of rapid postnatal brain growth on 6-aminolevulinic acid dehydratase (ALA-D) activity in brain, liver, kidney and blood of suckling rats. Toxicology 100:27–37
Wang Q, Zhao HU, Wang Q, Zhao HH, Chen JW, Hao QL, Gu KD, Zhu YX, Zhou YK, Ye LX (2010) d-Aminolevulinic acid dehydratase activity, urinary d-aminolevulinic acid concentration and zinc protoporphyrin level among people with low level of lead exposure. Int J Hyg Environ Health 213:52–58
Makino S, Tsruta H, Takata T (2000) Relationship between blood lead level and urinary ALA level in workers exposed to very low levels of lead. Ind Health 38:95–98
Bardullas U, Limón-Pacheco JH, Giordano M, Carrizales L, Mendoza-Trejo MS, Rodríguez VM (2009) Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice. Toxicol Appl Pharmacol 239:169–177
Jahan S, Ahmed S, Razzaq S, Amed H (2012) Adverse effects of arsenic exposure in the mammary glands of adult female rats. Pakistan J Zool 44(3):691–697
Kobayashi H, Yuyama A, Ishihara M, Matsusaka N (1987) Effects of arsenic on cholinergic parameters in brain in vitro. Neuropharmacology 26(12):1707–1713
Roy S, Chattoraj A, Bhattacharya S (2006) Arsenic-induced changes in optic tectal histoarchitecture and acetylcholinesterase-acetylcholine profile in Channa punctatus: amelioration by selenium. Comp Biochem Physiol 144:16–24
Yousef MI, El-Demerdash FM, Radwan FME (2008) Sodium arsenite induced biochemical perturbations in rats: ameliorating effect of curcumin. Food Chem Toxicol 46:3506–3511
Bhadauria S, Flora SJ (2004) Arsenic induced inhibition of delta-aminolevulinate dehydratase activity in rat blood and its response to meso 2,3-dimercaptosuccinic acid and monoisoamyl DMSA. Biomed Environ Sci 17(1):101–108
Wu H, Manonmanii K, Lam PKS, Huang SH, Wang JP, Ng JC (2004) Urinary arsenic speciation and porphyrins in C57Bl/6J mice chronically exposed to low doses of sodium arsenate. Toxicol Lett 154:149–157
Takser L, Mergler D, de Grosbois S, Smargiassi A, Lafond J (2004) Blood manganese content at birth and cord serum prolactin levels. Neurotoxicol Teratol 26:811–815
Aschner M (2006) Manganese as a potential confounder of serum prolactin. Environ Health Perspect 114(8):A458
Govonia S, Lucchia L, Battainia F, Spanoa PF, Trabucchia M (1984) Chronic lead treatment affects dopaminergic control of prolactin secretion in rat pituitary. Toxicol Lett 20(3):237–241
Adaudi AO, Aliu YO (1980) Urinary delta-aminolevulinic acid (ALA) excretion in humans and cattle as an index of exposure to lead. Vet Hum Toxicol 22(6):403–405
Marreilha dos Santos AP, Santos ML, Batoréu MC, Aschner M (2011) Prolactin is a peripheral marker of manganese neurotoxicity. Brain Res 1382:282–290
Wang G, Fowler BA (2008) Roles of biomarkers in evaluating interactions among mixtures of lead, cadmium and arsenic. Toxicol Appl Pharmacol 233:92–99
Whittaker MH, Wang G, Chen XQ, Lipsky M, Smith D, Gwiazda R, Fowler BA (2010) Exposure to Pb, Cd, and As mixtures potentiates the production of oxidative stress precursors: 30-day, 90-day, and 180-day drinking water studies in rats. Toxicol Appl Pharmacol 254(2):154–166
de Burbure C, Buchet JP, Leroyer A, Nisse C, Haguenoer JM, Mutti A et al (2006) Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels. Environ Health Perspect 114(4):584–590
Zhai R, Su S, Lu X, Liao R, Ge X, He M, Huang Y, Mai S, Lu X, Christiani D (2005) Proteomic profiling in the sera of workers occupationally exposed to arsenic and lead: identification of potential biomarkers. BioMetals 18:603–613
Jadhav SH, Sarkar SN, Kataria M, Tripathi HC (2007) Subchronic exposure to a mixture of groundwater-contaminating metals through drinking water induces oxidative stress in male rats. Environ Toxicol Pharmacol 23:205–211
Acknowledgments
The authors wish to acknowledge financial support from FCT strategic project PEst-OE/SAU/UI4013/2011, Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa and from the National Institute of Health (NIH R01ES10563).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andrade, V.M., Mateus, M.L., Batoréu, M.C. et al. Lead, Arsenic, and Manganese Metal Mixture Exposures: Focus on Biomarkers of Effect. Biol Trace Elem Res 166, 13–23 (2015). https://doi.org/10.1007/s12011-015-0267-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-015-0267-x